| 摘要 |
Disclosed is a method for treating hepatitis C virus (HCV) using the pan-genotypic HCV inhibitor { (2S,3R)-1-[(2S)-2-{ 5-[(2R,5R)-1-{ 3,5-difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]phenyl} -5-(6-fluoro-2-{ (2S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]pyrrolidin-2-yl} -1H-benzimidazol-5-yl)pyrrolidin-2-yl]-6-fluoro-1H-benzimidazol-2-yl} pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl} carbamate. In a preferred embodiment the treatment is independent of the specific genotype of HCV to be inhibited and said HCV is not subject to genotyping before said treatment. |
